Procept Biorobotics Corporation (PRCT) fundamentals score
Procept Biorobotics is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures and sells the AquaBeam Robotic System and HYDROS Robotic System, which are advanced, image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH.
Surgical & Medical Instruments & Apparatus · Healthcare · Listed on NASDAQ
Overall: 5.6 out of 10, Mixed fundamentals
- Growth: 5.7/10
- Profitability: 3.0/10
- Financial health: 6.0/10
- Earnings quality: 7.7/10
- Valuation: 6.9/10
Scores are calculated from Procept Biorobotics Corporation’s SEC filings, using the 12 months through 2026-06. Compare it with past big winners, check its flags, and see today’s price against its fundamentals in the full scorecard.
Other Healthcare stocks
- Nurix Therapeutics, Inc. (NRIX): 9.0/10
- Caredx, Inc. (CDNA): 8.9/10
- Dexcom, Inc. (DXCM): 8.8/10
- Exelixis Inc. (EXEL): 8.8/10
- Neurocrine Biosciences Inc. (NBIX): 8.7/10
- Progyny, Inc. (PGNY): 8.6/10
- Healthcare Services Group, Inc. (HCSG): 8.5/10
- Insulet Corporation (PODD): 8.5/10